Malignant but not naïve hepatocytes of human and rodent origin are killed by TNF after metabolic depletion of ATP by fructose.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study on primary hepatocytes and hepatoma cell lines; no clinical human data.
PubMed 20800309 · doi:10.1016/j.jhep.2010.05.024
What was done
The authors investigated fructose metabolism enzymes in primary human, rat, and mouse hepatocytes versus hepatoma cell lines. They assessed the effect of fructose-induced ATP depletion on TNF-mediated (and TNF/actinomycin D-mediated) apoptosis, testing the functional impact of hexokinase II (HKII) expression, hexokinase inhibition, and hypoxia-inducible factor 1 (HIF1) modulation.
What was found
Fructose caused ATP depletion and complete cytoprotection against TNF in primary mouse, rat, and human hepatocytes. Hepatic tumor cell lines exhibited increased HKII expression, showed no fructose-mediated ATP depletion, and remained vulnerable to TNF/ActD-induced apoptosis. Hexokinase inhibition restored ATP depletion in HepG2 cells, while HKII upregulation or overexpression in primary murine hepatocytes blocked ATP depletion and abolished cytoprotection against TNF. The abstract reports no numerical values.
Why it matters
The findings demonstrate a metabolic divergence between normal hepatocytes and hepatoma cells that could potentially be targeted to spare healthy liver tissue during TNF-based immunotherapy.
Limits
The study is restricted to in vitro primary cells and cell lines, lacking in vivo organismal data. The abstract reports no sample sizes, effect magnitudes, or statistical measures, and it does not establish in vivo safety or clinical efficacy.
Cited by
- context Fructose depletes mitochondrial ATP production in the liver.